Selling And Administration Expenses Veränderung Datum
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Acorda Therapeutics USD 21.82M 689K 2023-06
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
ALKERMES USD 167.95M 37.31M 2023-09
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
Amgen USD 1.76B 424M 2023-12
Arrowhead Research USD 26.19M 595K 2023-12
Biogen USD 608.5M 179.7M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Cara Therapeutics USD 6.72M 790K 2023-09
Cipla INR 10.91B 245.2M 2023-09
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.29M 163K 2023-09
CSL USD 1.29B 219.4M 2023-06
Cytokinetics USD 44.11M 4M 2023-12
Enanta Pharmaceuticals USD 13.8M 1.18M 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Grifols EUR 300.32M 28.7M 2023-09
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Heron Therapeutics USD 24.6M 11.84M 2023-09
Insmed USD 89.53M 1.1M 2023-12
Ligand Pharmaceuticals USD 15.99M 1.34M 2023-12
MannKind USD 20.54M 3.44M 2023-12
Merck EUR 1.42B 68M 2023-09
Moderna USD 470M 28M 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Teva Pharmaceutical Industries USD 844M 66M 2023-09
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Acorda Therapeutics Vertriebs- Und Verwaltungskosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.